Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
about
Performance and limitations of administrative data in the identification of AKI.Estimating long-term survival of critically ill patients: the PREDICT model.The effect of acute kidney injury on long-term health-related quality of life: a prospective follow-up study.The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.Survival after acute hemodialysis in Pennsylvania, 2005-2007: a retrospective cohort studyPredictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study.Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapyPrognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study.Acute renal failure in hospitalized patients: part I.Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis.Does age or bilateral disease influence the value of hip arthroplasty?Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysisAre QALYs based on time trade-off comparable?--A systematic review of TTO methodologies.Long-term quality of life in critically ill patients with acute kidney injury treated with renal replacement therapy: a matched cohort study.Non-beneficial treatments in hospital at the end of life: a systematic review on extent of the problem.Health-related quality of life as a predictor of mortality among survivors of AKI.Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units.Long-term outcome after intensive care: can we protect the kidney?Treatment intensity, age and outcome in medical ICU patients: results of a French administrative database.Health status, renal function, and quality of life after multiorgan failure and acute kidney injury requiring renal replacement therapy.Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest.Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo.Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysisMitochondrial Homeostasis in Acute Organ Failure.Cost-Effective Medicines for Stroke Prophylaxis in Patients with Atrial Fibrillation.Economic evaluation of continuous renal replacement therapy in acute renal failure.The empirical basis for determinations of medical futility.Withholding and withdrawing renal support in acute kidney injury.Financial aspects of renal replacement therapy in acute kidney injury.Acute kidney injury-epidemiology, outcomes and economics.The Price of a Helping Hand: Modeling the Outcomes and Costs of Bystander CPR.Acute Kidney Injury After Craniotomy Is Associated With Increased Mortality: A Cohort Study.Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.Identifying critically ill patients with acute kidney injury for whom renal replacement therapy is inappropriate: an exercise in futility?Evaluation of "Loss" and "End stage renal disease" after acute kidney injury defined by the Risk, Injury, Failure, Loss and ESRD classification in critically ill patients.Integration of APACHE II and III scoring systems in extremely high risk patients with acute renal failure treated by dialysis.Five-year cost-utility analysis of acute renal replacement therapy: a societal perspective.Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: a case series.Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis.AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States.
P2860
Q30741347-E883FBC7-EF83-40A6-902D-9E5216607C5AQ33370078-D420B251-46DA-48EB-BBBB-FFF2F2A48ED6Q33753342-1FA94EC2-918C-4F67-B486-CFDDA3D14F81Q33869039-CC05C3E4-95E2-42C2-B7ED-F08CFF067158Q34070732-F8C445C8-9A02-40D3-8BAA-EFF3EA9FC8B5Q34075439-E89AEF21-7817-4755-B4C6-F96C96F1B522Q34238047-126F5DD7-73FA-444D-A3A7-E4D7F1FF7390Q34480863-F88893E7-2434-48AC-939F-90DD0D30C09FQ34709917-CF2F7375-079F-4C78-9363-2C84A1D8CCA6Q34744355-C7012821-BABE-43FA-BF5F-52B2AD1EE9C6Q35802851-FDAFF69F-25EB-478C-800F-EEF1438A3716Q35804097-19957932-3E5C-44E1-874F-BF8FCE7106E2Q35896296-AB5D3CFC-D9ED-4C55-BABC-4703F474A59CQ35923742-9054600D-890C-4A68-B8A0-5D51C8A3D26FQ36063539-1D692DE7-1800-45DB-9783-68F3A1F77C49Q36067832-539B3998-4EDF-4CA1-9009-DAAC9128DD4AQ36392508-118116BD-DB46-46EB-A91C-7481EBAB9FA0Q36392776-A32BE948-D2F8-4114-A201-E18767A78C86Q36464135-187B6BA7-30BC-4C80-B8FB-270AE586BB7CQ36944140-927C20F8-C716-42F8-B3BD-938E591FFA12Q36955221-56D9C7F1-9D80-42BE-8D1D-DCC341EE5F93Q37174747-9F6425E0-D7BA-420B-8485-AC19D9D58007Q37303149-F501A529-CB43-4473-B7F9-6E61892E306FQ37417998-13AEC703-3173-45A1-85A7-96520C1A300BQ37495861-DB57CF19-A255-4644-B1A5-BA863225C845Q37556688-C68D8332-216C-4BED-8B50-C4D7B449409BQ37774286-8D6CCEBC-387C-4EFA-83C9-3A3408C2D033Q37868696-5AF880F3-7232-4201-80DA-CF71C7877EDCQ37868697-C0794946-E2F1-4AC5-9A75-FDD0E39546BEQ38180360-782F233D-A1C2-45BA-A197-03AB6D7CB67CQ38349201-FD96BB5D-8DFF-4404-A4A9-4BE62AED1470Q40233595-4771D717-1828-40F5-B547-600A13B522D2Q40721264-0CAC4054-F46A-4001-91F4-F7B570D8E36EQ40966758-E35D3FF2-368E-46B9-B5C0-A7D97FD6BFD2Q43276182-B95C01C4-21B5-4B2E-92ED-1AFBB0624A99Q43799838-F0576C37-5A3E-4421-B06C-4A98D05DD3EDQ43947740-5BE7C452-A5EB-4BD8-89A6-E080B6EA6DDEQ44020139-D73BEC1C-F9DC-4075-8482-1CD26333ACA9Q44589069-BB98A991-EB33-464B-84A0-D2143F9DFE0FQ45203047-6D1F9E1F-709D-4888-BD31-D4C5FED828D6
P2860
Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Outcomes and cost-effectivenes ...... comes and Risks of Treatments.
@en
type
label
Outcomes and cost-effectivenes ...... comes and Risks of Treatments.
@en
prefLabel
Outcomes and cost-effectivenes ...... comes and Risks of Treatments.
@en
P2093
P1476
Outcomes and cost-effectivenes ...... comes and Risks of Treatments.
@en
P2093
Connors AF Jr
Desbiens N
Fulkerson W
Phillips RS
P304
P356
10.7326/0003-4819-127-3-199708010-00003
P407
P577
1997-08-01T00:00:00Z